P/E at 61.15 vs Industry's 59.32: What the Data Shows for Apollo Hospitals Enterprise Ltd.

3 hours ago

Share Via

A price-to-earnings ratio of 61.15 compared with the hospital industry average of 59.32 reveals a modest premium for Apollo Hospitals Enterprise Ltd.. Previously rated Hold by MarketsMojo, the company’s rating was reassessed on 13 Apr 2026. While the one-year return of 11.78% comfortably outpaces the Sensex’s decline of 2.70%, the stock’s recent momentum shows a more nuanced picture, with a 3-month gain of 14.07% contrasting with a more modest 1-month return of 2.68%. The data paints a complex performance landscape across different timeframes.

Valuation Picture: Premium Reflects Confidence Amid Sector Dynamics

The current P/E of 61.15 for Apollo Hospitals Enterprise Ltd. stands slightly above the hospital industry’s average P/E of 59.32. This premium, though not excessive, suggests investors are willing to pay a higher multiple for the company’s earnings relative to its peers. Such a valuation often reflects expectations of superior earnings growth or operational resilience. However, the premium also raises questions about whether the stock’s price fully discounts potential risks or challenges within the sector. Apollo Hospitals Enterprise Ltd.’s market capitalisation of ₹1,11,447.49 crores places it firmly in the large-cap category, underscoring its prominence in the hospital sector.

Performance Across Timeframes: Divergent Momentum Signals

Examining returns over multiple periods reveals a stock that has outperformed the broader market consistently over the medium to long term. The one-year return of 11.78% contrasts sharply with the Sensex’s negative 2.70%, while the year-to-date gain of 10.06% also beats the Sensex’s decline of 9.56%. Over longer horizons, the stock’s performance is even more striking: a three-year return of 75.63% versus the Sensex’s 27.08%, a five-year return of 142.90% compared to 57.47%, and a ten-year return of 488.09% against 195.71% for the Sensex.

Shorter-term returns, however, show a more mixed picture. The stock’s 3-month gain of 14.07% is robust, outperforming the Sensex’s negative 5.84%, but the 1-month return of 2.68% trails the Sensex’s 4.74%. The 1-week gain of 1.27% also contrasts with the Sensex’s 1.84% decline, while the 1-day performance of 0.33% slightly underperforms the Sensex’s 0.53%. This pattern suggests recent volatility and a possible pause in momentum after a strong quarterly run — Apollo Hospitals Enterprise Ltd.’s short-term price action invites the question: is this a temporary consolidation or a sign of shifting investor sentiment?

Moving Average Configuration: Bullish Across All Key Averages

The technical setup for Apollo Hospitals Enterprise Ltd. is notably strong, with the stock trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This alignment indicates sustained upward momentum and a bullish trend across both short and long-term horizons. The stock is currently just 4.69% below its 52-week high of ₹8,099, signalling proximity to recent peak levels. Such a configuration often reflects investor confidence and can act as a support base for further gains. However, the slight underperformance relative to the sector today (-0.79%) suggests some caution in the immediate term.

Sector Performance Context: Hospital Industry Shows Mixed Results

The hospital sector, within which Apollo Hospitals Enterprise Ltd. operates, has experienced a varied performance landscape recently. While some companies have reported strong earnings growth and operational improvements, others have faced headwinds from regulatory pressures and rising costs. The sector’s average P/E of 59.32 reflects a valuation level that is elevated but consistent with expectations of growth and resilience in healthcare services. Within this context, Apollo Hospitals Enterprise Ltd.’s premium valuation and strong moving average positioning suggest it remains a leading player, though sector-wide challenges remain relevant.

Rating Reassessment: Previously Rated Hold, Now Updated

On 13 Apr 2026, the rating for Apollo Hospitals Enterprise Ltd. was updated from its previous Hold status. This reassessment reflects a comprehensive analysis of the company’s fundamentals, valuation, and technical outlook. The previous Mojo Score of 75.0 and the large-cap market cap grade underpin the stock’s profile as a significant sector constituent. The updated rating invites investors to consider: should investors in Apollo Hospitals hold, buy more, or reconsider?

Conclusion: Data Reflects a Stock with Strong Long-Term Performance and Mixed Short-Term Signals

The data for Apollo Hospitals Enterprise Ltd. reveals a company trading at a slight valuation premium relative to its hospital industry peers, supported by a robust moving average configuration and strong long-term returns. While recent short-term performance shows some deceleration relative to the Sensex and sector, the stock remains near its 52-week high and above all key moving averages, signalling underlying strength. The rating update from Hold to a new status reflects this nuanced picture, balancing valuation, momentum, and sector dynamics. Investors may well ask: what is the current rating for Apollo Hospitals Enterprise Ltd. and how should it influence portfolio decisions?

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)

MOJO SCORE